Page last updated: 2024-12-08
5-hydroxypipecolic acid
Description
5-hydroxypipecolic acid: RN given refers to cpd without isomeric designation [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
5-hydroxypipecolic acid : A piperidinemonocarboxylic acid that is pipecolic acid with a hydroxy substituent at position 5. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
Cross-References
| ID Source | ID |
|---|
| PubMed CID | 151730 |
| CHEBI ID | 74048 |
| SCHEMBL ID | 497510 |
| MeSH ID | M0151721 |
Synonyms (34)
| Synonym |
|---|
| 5-hydroxypipecolic acid |
| AKOS000280489 |
| 5-hydroxypiperidine-2-carboxylic acid |
| unii-0u5r8qif9u |
| 2-piperidinecarboxylic acid, 5-hydroxy- |
| 0u5r8qif9u , |
| 13096-31-6 |
| CHEBI:74048 |
| PB18272 |
| AKOS023397775 |
| racemic (2r*,5s*)-5-hydroxypiperidine-2-carboxylic acid |
| SCHEMBL497510 |
| 5-hydroxy-2-piperidinecarboxylic acid # |
| 5-hydroxy-2-piperidinecarboxylic acid |
| 5-hydroxy piperidine-2-carboxylic acid |
| l-trans-5-hydroxy-2-piperidinecarboxylic acid |
| mfcd08694639 |
| DTXSID10926984 |
| FT-0733616 |
| Q27144360 |
| SY232837 |
| F30864 |
| ZB1686 |
| BS-15164 |
| SB20390 |
| SB22744 |
| SB37393 |
| A904945 |
| SB41273 |
| SY098400 |
| CS-0138318 |
| 5-hydroxypiperidine-2-carboxylicacid |
| EN300-188200 |
| Z1198181269 |
Roles (1)
| Role | Description |
|---|
| metabolite | Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites. |
| [role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Drug Classes (1)
| Class | Description |
|---|
| piperidinemonocarboxylic acid | Any member of the class of piperidines in which one of the carbons of the piperidine ring is substituted by a carboxy group. |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Research
Studies (5)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|
| pre-1990 | 3 (60.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.42
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| Metric | This Compound (vs All) |
|---|
| Research Demand Index | 12.42 (24.57) | | Research Supply Index | 1.79 (2.92) | | Research Growth Index | 4.21 (4.65) | | Search Engine Demand Index | 0.00 (26.88) | | Search Engine Supply Index | 0.00 (0.95) |
| |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |